Physicians’ Trust in the FDA’s Use of Product-Specific Pathways for Generic Drug Approval

Aaron S. Kesselheim; Wesley Eddings; Tara Raj; Eric G. Campbell; Jessica M. Franklin; Kathryn M. Ross; Lisa A. Fulchino; Jerry Avorn; Joshua J. Gagne

doi:10.1371/journal.pone.0163339

Loading metrics

Open Access

Peer-reviewed

Research Article

Physicians’ Trust in the FDA’s Use of Product-Specific Pathways for Generic Drug Approval

Aaron S. Kesselheim ,

* E-mail: akesselheim@partners.org

Affiliation Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, United States of America
⨯
Wesley Eddings,

Affiliation Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, United States of America
⨯
Tara Raj,

Affiliation Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, United States of America
⨯
Eric G. Campbell,

Affiliation Mongan Institute for Health Policy, Massachusetts General Hospital, Boston, MA, United States of America
⨯
Jessica M. Franklin,

Affiliation Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, United States of America
⨯
Kathryn M. Ross,

Affiliation American Board of Internal Medicine, Philadelphia, PA, United States of America
⨯
Lisa A. Fulchino,

Affiliation Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, United States of America
⨯
Jerry Avorn,

Affiliation Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, United States of America
⨯
Joshua J. Gagne

Affiliation Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, United States of America
⨯

Physicians’ Trust in the FDA’s Use of Product-Specific Pathways for Generic Drug Approval

Aaron S. Kesselheim,
Wesley Eddings,
Tara Raj,
Eric G. Campbell,
Jessica M. Franklin,
Kathryn M. Ross,
Lisa A. Fulchino,
Jerry Avorn,
Joshua J. Gagne

Published: October 21, 2016
https://doi.org/10.1371/journal.pone.0163339

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Physicians
Is the Subject Area "Physicians" applicable to this article?

Thanks for your feedback.
Comparators
Is the Subject Area "Comparators" applicable to this article?

Thanks for your feedback.
Surveys
Is the Subject Area "Surveys" applicable to this article?

Thanks for your feedback.
Calcitonin
Is the Subject Area "Calcitonin" applicable to this article?

Thanks for your feedback.
Drug research and development
Is the Subject Area "Drug research and development" applicable to this article?

Thanks for your feedback.
Vancomycin
Is the Subject Area "Vancomycin" applicable to this article?

Thanks for your feedback.
Drug administration
Is the Subject Area "Drug administration" applicable to this article?

Thanks for your feedback.
Pharmacists
Is the Subject Area "Pharmacists" applicable to this article?

Thanks for your feedback.